• Immunofluorescence analysis of HepG2 cells using Cytokeratin 18 (KRT18) Rabbit polyclonal antibody (STJ116405) at dilution of 1:300 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.
  • Immunohistochemistry analysis of Cytokeratin 18 (KRT18) in paraffin-embedded human small intestine using Cytokeratin 18 (KRT18) Rabbit polyclonal antibody (STJ116405) at dilution of 1:100 (40x lens). Perform microwave antigen retrieval with 10 mM PBS buffer pH 7. 2 before commencing with immunohistochemistry staining protocol.
  • Immunohistochemistry analysis of Cytokeratin 18 (KRT18) in paraffin-embedded human liver cancer using Cytokeratin 18 (KRT18) Rabbit polyclonal antibody (STJ116405) at dilution of 1:100 (40x lens). Perform microwave antigen retrieval with 10 mM PBS buffer pH 7. 2 before commencing with immunohistochemistry staining protocol.
  • Western blot analysis of various lysates, using Cytokeratin 18 (KRT18) Rabbit polyclonal antibody (STJ116405) at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 0. 5s.

Anti-KRT18 antibody (127-430) (STJ116405)

SKU:
STJ116405

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/IHC/IF
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cytokeratin-18 (127-430) is suitable for use in Western Blot, Immunohistochemistry and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:1000-1:5000
IHC-P 1:50-1:100
IF/ICC 1:100-1:500
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: KRT18
Gene ID: 3875
Uniprot ID: K1C18_HUMAN
Immunogen Region: 127-430
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 127-430 of human Cytokeratin 18 (KRT18) (NP_000215.1).
Immunogen Sequence: SHYFKIIEDLRAQIFANTVD NARIVLQIDNARLAADDFRV KYETELAMRQSVENDIHGLR KVIDDTNITRLQLETEIEAL KEELLFMKKNHEEEVKGLQA QIASSGLTVEVDAPKSQDLA KIMADIRAQYDELARKNREE LDKYWSQQIEESTTVVTTQS AEVGAAETTLTELRRTVQSL EIDLDSMRNLKASLENSLRE VEARYALQMEQLNGILLHLE SELAQTRAEGQRQAQEYEA
Tissue Specificity Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma.
Post Translational Modifications Phosphorylation at Ser-34 increases during mitosis. Hyperphosphorylated at Ser-53 in diseased cirrhosis liver. Phosphorylation increases by IL-6. Proteolytically cleaved by caspases during epithelial cell apoptosis. Cleavage occurs at Asp-238 by either caspase-3, caspase-6 or caspase-7. O-GlcNAcylation increases solubility, and decreases stability by inducing proteasomal degradation.
Function Involved in the uptake of thrombin-antithrombin complexes by hepatic cells. When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.
Protein Name Keratin - Type I Cytoskeletal 18
Cell Proliferation-Inducing Gene 46 Protein
Cytokeratin-18
Ck-18
Keratin-18
K18
Database Links Reactome: R-HSA-6805567
Reactome: R-HSA-6809371
Cellular Localisation Nucleus Matrix
Cytoplasm
Perinuclear Region
Nucleus
Nucleolus
Alternative Antibody Names Anti-Keratin - Type I Cytoskeletal 18 antibody
Anti-Cell Proliferation-Inducing Gene 46 Protein antibody
Anti-Cytokeratin-18 antibody
Anti-Ck-18 antibody
Anti-Keratin-18 antibody
Anti-K18 antibody
Anti-KRT18 antibody
Anti-CYK18 antibody
Anti-PIG46 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance